- Home
- BUSE vs AMPH Comparison
BUSE vs AMPH Comparison
Compare BUSE & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BUSE
- AMPH
- Stock Information
- Founded
- BUSE 1868
- AMPH 1996
- Country
- BUSE United States
- AMPH United States
- Employees
- BUSE N/A
- AMPH N/A
- Industry
- BUSE Major Banks
- AMPH Biotechnology: Pharmaceutical Preparations
- Sector
- BUSE Finance
- AMPH Health Care
- Exchange
- BUSE Nasdaq
- AMPH Nasdaq
- Market Cap
- BUSE 1.4B
- AMPH 1.3B
- IPO Year
- BUSE N/A
- AMPH 2014
- Fundamental
- Price
- BUSE $21.57
- AMPH $28.29
- Analyst Decision
- BUSE Buy
- AMPH Hold
- Analyst Count
- BUSE 4
- AMPH 3
- Target Price
- BUSE $28.00
- AMPH $43.50
- AVG Volume (30 Days)
- BUSE 507.2K
- AMPH 569.1K
- Earning Date
- BUSE 04-22-2025
- AMPH 05-07-2025
- Dividend Yield
- BUSE 4.64%
- AMPH N/A
- EPS Growth
- BUSE N/A
- AMPH 17.69
- EPS
- BUSE 1.98
- AMPH 3.06
- Revenue
- BUSE $453,703,000.00
- AMPH $731,967,000.00
- Revenue This Year
- BUSE $64.85
- AMPH $2.60
- Revenue Next Year
- BUSE $12.48
- AMPH $9.42
- P/E Ratio
- BUSE $10.89
- AMPH $9.25
- Revenue Growth
- BUSE 3.25
- AMPH 13.59
- 52 Week Low
- BUSE $21.13
- AMPH $25.89
- 52 Week High
- BUSE $28.97
- AMPH $53.96
- Technical
- Relative Strength Index (RSI)
- BUSE 37.71
- AMPH 43.50
- Support Level
- BUSE $21.72
- AMPH $28.01
- Resistance Level
- BUSE $22.64
- AMPH $29.18
- Average True Range (ATR)
- BUSE 0.49
- AMPH 0.79
- MACD
- BUSE 0.02
- AMPH 0.35
- Stochastic Oscillator
- BUSE 29.14
- AMPH 72.95
About BUSE First Busey Corporation
First Busey Corporation is a financial holding company, whose subsidiaries provides retail and commercial banking services, remittance processing, and offers financial products and services with banking centers in Illinois, Missouri, Florida, and Indiana. The company's operations are managed through three operating segments consisting of Banking, FirsTech, and Wealth Management. The banking segment generates a vast majority of its revenue.
About AMPH Amphastar Pharmaceuticals Inc.
Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.